Tetralogic Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:TLOG)

$0.03 0.00 (0.00 %)
(As of 02/20/2018 01:10 AM ET)
Previous Close$0.03
Today's RangeN/A
52-Week Range$0.01 - $0.07
Average Volume32,869 shs
Market Capitalization$627,900.00
P/E Ratio-0.02
Dividend YieldN/A

About Tetralogic Pharmaceuticals (OTCMKTS:TLOG)

Tetralogic Pharmaceuticals logoTetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Receive TLOG News and Ratings via Email

Sign-up to receive the latest news and ratings for TLOG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-0.0154878048780488
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares24,470,000

Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Frequently Asked Questions

What is Tetralogic Pharmaceuticals' stock symbol?

Tetralogic Pharmaceuticals trades on the OTCMKTS under the ticker symbol "TLOG."

How were Tetralogic Pharmaceuticals' earnings last quarter?

Tetralogic Pharmaceuticals Corp (OTCMKTS:TLOG) announced its quarterly earnings results on Thursday, February, 26th. The biopharmaceutical company reported ($0.53) EPS for the quarter, missing the Zacks' consensus estimate of ($0.39) by $0.14. View Tetralogic Pharmaceuticals' Earnings History.

Who are some of Tetralogic Pharmaceuticals' key competitors?

Who are Tetralogic Pharmaceuticals' key executives?

Tetralogic Pharmaceuticals' management team includes the folowing people:

  • Andrew L. Pecora M.D., Independent Chairman of the Board

How do I buy Tetralogic Pharmaceuticals stock?

Shares of Tetralogic Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tetralogic Pharmaceuticals' stock price today?

One share of Tetralogic Pharmaceuticals stock can currently be purchased for approximately $0.03.

How big of a company is Tetralogic Pharmaceuticals?

Tetralogic Pharmaceuticals has a market capitalization of $627,900.00. The biopharmaceutical company earns $-49,720,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis.

How can I contact Tetralogic Pharmaceuticals?

Tetralogic Pharmaceuticals' mailing address is PO Box 1305, PAOLI, PA 19301-5305, United States. The biopharmaceutical company can be reached via phone at +1-610-8899900 or via email at [email protected]

MarketBeat Community Rating for Tetralogic Pharmaceuticals (TLOG)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  103
MarketBeat's community ratings are surveys of what our community members think about Tetralogic Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Earnings History and Estimates Chart

Earnings by Quarter for Tetralogic Pharmaceuticals (OTCMKTS:TLOG)

Tetralogic Pharmaceuticals (OTCMKTS TLOG) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016Q3 2016($0.08)ViewN/AView Earnings Details
8/11/2016Q2 2016($0.22)ViewN/AView Earnings Details
5/4/2016Q1 2016($0.45)ViewN/AView Earnings Details
3/16/2016Q4 2015($0.76)ViewN/AView Earnings Details
11/4/2015Q3 2015($0.34)ViewN/AView Earnings Details
8/5/2015Q2 2015($0.32)ViewN/AView Earnings Details
5/14/2015Q1 2015($0.25)ViewN/AView Earnings Details
2/26/2015Q414($0.39)($0.53)$1.13 millionViewN/AView Earnings Details
11/5/2014Q314($4.34)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Tetralogic Pharmaceuticals (OTCMKTS:TLOG)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tetralogic Pharmaceuticals (OTCMKTS TLOG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.40%
Institutional Ownership Percentage: 0.02%
Insider Trades by Quarter for Tetralogic Pharmaceuticals (OTCMKTS:TLOG)

Tetralogic Pharmaceuticals (OTCMKTS TLOG) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell333,630$0.17$56,717.10View SEC Filing  
2/5/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell1,415,490$0.18$254,788.20View SEC Filing  
2/2/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell369,132$0.19$70,135.08View SEC Filing  
1/28/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell311,930$0.28$87,340.40View SEC Filing  
7/10/2015Andrew L PecoraDirectorBuy50,000$2.68$134,000.00View SEC Filing  
7/9/2015Andrew L PecoraDirectorBuy50,000$2.40$120,000.00View SEC Filing  
7/2/2015Paul J SchmittDirectorBuy10,000$2.34$23,400.00View SEC Filing  
3/27/2015Pete A MeyersCFOBuy5,000$4.35$21,750.00View SEC Filing  
3/26/2015J Kevin BuchiCEOBuy5,000$4.23$21,150.00View SEC Filing  
1/7/2015J Kevin BuchiCEOBuy5,000$5.04$25,200.00View SEC Filing  
12/10/2014Colin Glenn BegleySVPBuy5,900$6.16$36,344.00View SEC Filing  
12/9/2014J Kevin BuchiCEOBuy5,000$6.01$30,050.00View SEC Filing  
12/4/2014Pete A MeyersCFOBuy1,034$4.94$5,107.96View SEC Filing  
12/2/2014J Kevin BuchiCEOBuy10,000$4.99$49,900.00View SEC Filing  
11/26/2014Colin Glenn BegleySVPBuy3,100$4.86$15,066.00View SEC Filing  
11/26/2014Lesley RussellCOOBuy20,000$4.90$98,000.00View SEC Filing  
11/25/2014Colin Glenn BegleySVPBuy2,000$4.85$9,700.00View SEC Filing  
11/18/2014J Kevin BuchiCEOBuy10,000$4.82$48,200.00View SEC Filing  
11/17/2014Andrew L PecoraDirectorBuy20,000$4.53$90,600.00View SEC Filing  
11/12/2014Peter A MeyersCFOBuy5,000$3.98$19,900.00View SEC Filing  
11/11/2014J Kevin BuchiCEOBuy10,000$3.93$39,300.00View SEC Filing  
11/10/2014Paul J SchmittDirectorBuy20,000$4.10$82,000.00View SEC Filing  
12/17/2013J Kevin BuchiCEOBuy285,714$7.00$1,999,998.00View SEC Filing  
12/17/2013James N WoodyDirectorBuy261,427$7.00$1,829,989.00View SEC Filing  
12/17/2013Peter A MeyersCFOBuy142,857$7.00$999,999.00View SEC Filing  
12/17/2013Ventures Vii Lp HealthcareMajor ShareholderBuy713,463$7.00$4,994,241.00View SEC Filing  
(Data available from 1/1/2013 forward)


Tetralogic Pharmaceuticals (OTCMKTS TLOG) News Headlines

Critical Review: Sevion Therapeutics (SVON) versus Tetralogic Pharmaceuticals (TLOG)Critical Review: Sevion Therapeutics (SVON) versus Tetralogic Pharmaceuticals (TLOG)
www.americanbankingnews.com - January 26 at 3:12 AM
Jazz Pharmaceuticals (JAZZ) & TetraLogic Pharmaceuticals (TLOG) Head to Head ReviewJazz Pharmaceuticals (JAZZ) & TetraLogic Pharmaceuticals (TLOG) Head to Head Review
www.americanbankingnews.com - November 27 at 1:38 AM
Reviewing XOMA Corporation (XOMA) and TetraLogic Pharmaceuticals Corporation (TLOG)Reviewing XOMA Corporation (XOMA) and TetraLogic Pharmaceuticals Corporation (TLOG)
www.americanbankingnews.com - November 17 at 3:06 AM

SEC Filings

Tetralogic Pharmaceuticals (OTCMKTS:TLOG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Income Statement, Balance Sheet and Cash Flow Statement


Tetralogic Pharmaceuticals (OTCMKTS TLOG) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.